PUK15 a Managed Care Cost-Offset Model for Ferric Citrate, an Experimental Phosphate Binder That Can Reduce the Use of Erythropoiesis-Stimulating Agents and Intravenous Iron in Hemodialysis Patients With Hyperphosphatemia

Value in Health - United Kingdom

doi 10.1016/j.jval.2012.03.835